Phase II Trial of Immunonutrition in Hepatectomy
Key facts
- Where
- Mumbai, IndiaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT07395635, who can take part
Where in India
- Dr.Shraddha PatkarMumbai, IndiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Tata Memorial Centre
- Trial code
- NCT07395635
- Record updated
- 9 February 2026
- Original description
A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver TumorsRead full original descriptionShow less
Impact of Immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors: A Randomized Controlled Phase II Trial
A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors
Inclusion: Patients with liver tumors planned for major hepatectomies (defined as resection of >/= 3 liver segments); Age above 18 years; ASA class I-III.
Exclusion: Preoperative severe renal failure (estimated glomerular filtration rate < 30 ml/min); History of hypersensitivity to arginine, omega-3 fatty acids, or nucleotide 3. Inability to take oral nutrition; Pregnancy 5. Mental condition rendering the subject unable to understand the nature, endpoints and consequences of the trial.